Ex-Pharma CEO Denied 3rd Circ. Rehearing In $1M FBAR Case
The Third Circuit declined Tuesday to reconsider its decision backing $1 million in penalties imposed against a former pharmaceutical CEO for failing to report his Swiss bank accounts....To view the full article, register now.
Already a subscriber? Click here to view full article